Financial Statements Directors’ Report for the year ended 31 December 2024 The Directors have pleasure in submitting their report and the audited financial statements of the Group and of the Company for the financial year ended 31 December 2024. PRINCIPAL ACTIVITIES The principal activities of the Company are those relating to investment holding, whilst the principal activities of the subsidiaries are as stated in note 38 to the financial statements. There has been no significant change in the nature of these activities during the financial year. SUBSIDIARIES The details of the Company’s subsidiaries are disclosed in note 38 to the financial statements. RESULTS Group RM’mil Company RM’mil Profit for the year attributable to: Owners of the Company 2,657 1,120 Non-controlling interests 505 – 3,162 1,120 RESERVES AND PROVISIONS Except as disclosed in the financial statements, there were no material transfers to or from reserves and provisions during the financial year under review. DIVIDENDS Since the end of the previous financial year, the Company paid a final single tier cash dividend of 5.5 sen per ordinary share amounting to RM484 million for the financial year ended 31 December 2023 on 26 April 2024, and an interim single tier cash dividend of 4.5 sen per ordinary share amounting to RM397 million for the financial year ended 31 December 2024 on 30 October 2024. The Board of Directors has declared that a final single tier cash dividend of 5.5 sen per ordinary share for the financial year ended 31 December 2024 to be paid on 28 April 2025 to shareholders whose names appear in the Record of Depositors of Bursa Malaysia Depository Sdn. Bhd. and The Central Depository (Pte) Limited (“CDP”) at the close of business on 28 March 2025. The Company shall apply the RM:SGD noon middle rate as disclosed in the Bank Negara Malaysia’s website on 28 March 2025 as the basis for computing the dividend quantum to be paid in SGD to the Singapore investors whose Company’s shares are traded on SGX-ST. DIRECTORS OF THE COMPANY Directors who served during the financial year until the date of this report are: Tan Sri Dr Nik Norzrul Thani Bin N. Hassan Thani Appointed on 26 June 2024 Tomo Nagahiro Lim Tsin-Lin Mehmet Ali Aydinlar Mohd Shahazwan Bin Mohd Harris Jill Margaret Watts Dato’ Sri Muthanna Bin Abdullah Satoshi Tanaka Yoichiro Endo Appointed on 1 April 2024 Chua Bin Hwee Appointed on 14 August 2024 Mok Jia Mei (Alternate Director to Lim Tsin-Lin) Takeshi Akutsu Resigned on 31 March 2024 Tan Sri Mohammed Azlan Bin Hashim Retired on 28 May 2024 Ong Ai Lin Retired on 28 May 2024 IHH Healthcare Berhad | Annual Report 2024 114
RkJQdWJsaXNoZXIy NDgzMzc=